Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CHIKV monoclonal antibodies directed against the E2 structural protein

Anti-CHIKV monoclonal antibodies directed against the E2 structural protein

US Patent 11286295 · Granted Mar 29, 2022

Estimated economic value: $13,600,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fc containing polypeptides with altered glycosylation and reduced effector funct2025
scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidi2025
Anti-alpha beta TCR binding polypeptides with reduced fragmentation2025
Tumor-specific cleavable linkers2025
Anti-CHIKV antibodies and uses thereof2025
Anti-CHIKV antibodies and uses thereof2025
Anti-CHIKV antibodies and uses thereof2025
Anti-CHIKV antibodies and uses thereof2025
Anti-CHIKV antibodies and uses thereof2025
Anti-CHIKV antibodies and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025